
Getting to Know Rene Y. Choi, MD, PhD
Texas Retina was fortunate to have board-certified ophthalmologist and retina specialist Rene Choi, MD, PhD, join our team in September 2020, and he currently cares for patients in our Denton and Frisco
read more
We Love Our Patients!
At Texas Retina, our patients are at the HEART of everything we do. Thank you for placing your trust in us. Happy Valentine’s Day!
read more
Dr. Abbey Discusses Injectable Retina Treatments on AAO Podcast
On a recent episode of the American Academy of Ophthalmology’s “Experts InSight” podcast, Texas Retina’s Ashkan Abbey, MD, joined Ehsan Rahimy, MD, and host Jay Shridhar, MD, to discuss recent developments in
read more
Dr. Christopher Fuller Won Best in Show at Telluride Retina Film Festival
This past weekend, Texas Retina’s Christopher G. Fuller, MD, presented a video at the Telluride Retina Film Festival, a three-day conference that brings together retina specialists from throughout the Western hemisphere to
read more
Texas Retina Research Team Publishes New Study on Wet AMD Treatment
Texas Retina’s Ashkan Abbey, MD; Paige Abril, BS; and Rachel McCullough, BS, recently published a retrospective study in the peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Retina titled, “Outcomes of Intravitreal Aflibercept
read more
Honoring the Life and Legacy of Texas Retina Co-founder Albert Vaiser, MD
It is with great sadness that Texas Retina announces the passing of one of its three founders, Albert Vaiser MD, on Saturday, February 1, 2025, after a brief illness. Dr. Vaiser had celebrated
read more
Dr. Wang Discussed CLARITY Clinical Trial Enrollment at Presentation in Miami
Robert Wang, MD, Texas Retina’s Director of Clinical Research for Plano, recently spoke about the CLARITY clinical trial at a meeting of retina specialists held in Miami, Florida. A global, multi-center Phase
read more
Dr. Abbey Presented First-Year Results of DAVIO 2 Clinical Trial at Hawaiian Eye and Retina 2025
Texas Retina’s Ashkan M. Abbey, MD, presented “DAVIO 2: Year 1 Results from a Phase 2, Multicenter, Non-Inferiority Trial of EYP-1901 (Vorolanib Intravitreal Insert) versus Aflibercept for Previously-Treated Wet Age-Related Macular Degeneration”
read more
Understanding Your Insurance Coverage in the New Year: How Prior Authorizations Can Impact Retina Care
Health insurance policies and coverage vary greatly. As we start a new year, it is important to understand how your specific plan works and how that can affect your retina care. Referrals
read more